Linjia Haoyi Completes Nearly RMB 100 Million Financing to Pioneer an Innovative Family Healthcare Service Model

Recently, VCBeat learned thatLinjia Haoyi, a home healthcare provider with both offline institutions and a digital platform, has completed a new round of financing nearing RMB 100 million, co-led by Kuanping Capital and Detong Capital, with existing shareholder CoWin Ventures continuing to participate.

Linjia Haoyi, founded in 2016, is a technology-driven healthcare services enterprise. Guided by its core philosophy of “making healthcare accessible, warm, and trustworthy,” the company is committed to comprehensively enhancing community medical service capabilities. By adopting an integrated model that combines general practice with specialty care, online with offline services, and medical treatment with health management, Linjia Haoyi provides convenient, efficient, and high-quality general practice and family healthcare services to a broad user base. The company strives to pioneer innovative models of healthcare delivery and become a respected healthcare service provider.

Since its inception, Linjia Haoyi has been highly favored by investment institutions for its advantages, including a maker-oriented core philosophy, a team of top-tier talent, an intelligent healthcare experience, and a collaborative new medical ecosystem. The company has successfully secured three rounds of financing from investors such as CoWin Ventures, Yuansheng Venture Capital, and Shulan Medical.

In 2020, the Linjia Haoyi team overcame the impact of the pandemic, rapidly built a new development model, achieved high-quality corporate growth, doubled its operating revenue, and created greater value for users. Following this round of financing, the company will continue to advance operational standardization and digital upgrades, explore the establishment of a regional medical sub-center model, and leverage the spillover resources of non-complex medical services from tertiary Grade A hospitals, ultimately making healthcare services more “convenient” and “high-quality.”

In January 2021, ZhongAn Insurance, Shulan Healthcare, and Linjia Haoyi completed the signing of a tripartite strategic cooperation agreement. The three parties will engage in comprehensive collaboration across areas including medical care coverage, standardization of medical services, direct billing insurance partnerships, building a closed-loop healthcare service ecosystem and smart healthcare brand, and exploring regional managed care services.Ou Jinyi, Executive Director of ZhongAn Insurance; Zheng Jie, President of Shulan Healthcare; and Luo Lin, Founder of Linjia Haoyi, jointly attended the signing ceremony.

All three parties unanimously agreed to fully leverage their respective resource advantages to further promote long-term, comprehensive, and in-depth cooperation. They will jointly explore and cultivate the market, actively develop a closed-loop service model integrating specialized care, primary care, online services, and offline services, and foster efficient collaboration between healthcare providers and payers. These efforts aim to contribute to the Healthy China initiative, ultimately establishing a patient-centered, sustainable healthcare service model that realizes a medical service ecosystem where minor ailments are treated in the community, major diseases are managed in hospitals, and rehabilitation takes place back in the community.

In the future, Linjia Haoyi will leverage capital to effectively implement tiered diagnosis and treatment, adhere to a patient-centric and physician-focused approach, promote diversified payment models, meet the healthcare needs of individuals and families, and gradually realize its vision of “data-driven service upgrades to become a respected healthcare provider.”

As an investor in this round,Li Huihui, Founding Partner and CEO of Kuanping Capital, stated“Community healthcare is the service model in the broader health sector that is most closely aligned with public livelihood. It is built on trust, grounded in specialization, centered on convenience, and connected through empathy. With the deepening implementation of China’s tiered diagnosis and treatment system, it has become an inevitable trend for basic medical needs to return to the community level, ushering in a period of robust growth for high-quality chain community health centers. Kuanping Capital strongly affirms Neighbor Good Doctor’s long-term commitment to refined, technology-driven operations, as well as its original aspiration to serve patients and foster warm neighborhood relationships. Meanwhile, the Kuanping team will actively empower the company by integrating resources from various ecosystem partners to achieve symbiotic growth and mutual success.”

Tian Lixin, Founding Managing Partner of Detong Capital, stated"Linjia Haoyi’s service network and quality of care have gained recognition within the region, with its brand effect beginning to take shape. The company is committed to addressing the pain point of insufficient access to convenient, high-quality medical services for young professionals and new middle-class families in rapidly developing areas, aligning with both market demand and national policy directions. By combining expertise in healthcare institution management with internet platform development and operational capabilities, our team is confident that Linjia Haoyi will continue to build a high-quality, online-offline integrated primary care network in the future. This will comprehensively enhance community-based primary healthcare services, establishing Linjia Haoyi as a model for innovative urban community healthcare operations in China."

Wen Gang, Partner at CoWin Ventures, stated“CoWin Ventures has long been bullish on technology-driven healthcare service companies with an innovative DNA, and Neighbor Good Doctor represents a critically important component of our tech-enabled healthcare services portfolio. In the current context of the COVID-19 pandemic, there is a particular need for professional, efficient, and driven teams like that of Neighbor Good Doctor to continue exploring this field. As a longstanding shareholder, CoWin has witnessed the entire journey of Neighbor Good Doctor from its inception to its growth into China’s leading provider of high-quality community-based home healthcare services, and we will continue to grow alongside the team.”

Community-based home healthcare is a key focus of the nation’s current healthcare reform. Against the backdrop of tiered diagnosis and treatment, primary care services and family doctor services have been elevated to new heights. Meanwhile, there is a growing need for high-quality service providers to meet users’ personalized and differentiated demands. As a leader in this field, Linjia Haoyi will continue to explore deeply in the future.

Kuanping Capital, established in 2016, is a private equity fund focused on the healthcare and wellness sector. The Kuanping team adheres to research-driven, strategy-oriented active investment, deeply engaging with the industry and partnering with outstanding entrepreneurs to create value through professionalism. Kuanping Capital has invested in leading companies in various niche sectors, including Beijing Medos and Nuanwa Technology.

Detong Capital is a leading professional private equity fund management firm in China, with assets under management nearing RMB 20 billion. In recent years, it has nurtured six listed companies and a cohort of early-stage enterprises with significant technological breakthroughs in the healthcare sector, including Chipscreen Biosciences, the first innovative drug company to list on the STAR Market. Detong Capital is also among the earliest investment institutions to establish strategic partnerships with multiple local governments and prominent industrial groups, providing comprehensive services and support to its portfolio companies.

CoWin Ventures, established in 2009, specializes in investments in the healthcare and IT hard-tech sectors. It currently operates 15 funds independently, with cumulative assets under management of approximately RMB 5 billion, providing financial and resource support to over 100 outstanding teams and projects. CoWin Ventures has empowered more than 30 industry-leading companies, including InnoLight Technology, Jutze Intelligence, Taimei Medical Technology, Cytek Biosciences, Genetron Health, and Linjia Haoyi. Furthermore, it has facilitated the successful public listings of more than ten high-tech enterprises, such as Tongcheng-Elong, Neusoft Reach, Huaxing Zhiyuan, and Aolian Electronics.